Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Association Between Apelin and Atrial Fibrillation in Patients With High Risk of Ischemic Stroke

A. Bohm, P. Snopek, L. Tothova, B. Bezak, N. Jajcay, M. Vachalcova, T. Uher, M. Kurecko, V. Kissova, K. Danova, P. Olejnik, P. Michalek, T. Hlavata, K. Petrikova, V. Mojto, J. Kyselovic, S. Farsky

. 2021 ; 8 (-) : 742601. [pub] 20211012

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc22001569

Background: Atrial fibrillation (AF) is associated with high risk of stroke preventable by timely initiation of anticoagulation. Currently available screening tools based on ECG are not optimal due to inconvenience and high costs. Aim of this study was to study the diagnostic value of apelin for AF in patients with high risk of stroke. Methods: We designed a multicenter, matched-cohort study. The population consisted of three study groups: a healthy control group (34 patients) and two matched groups of 60 patients with high risk of stroke (AF and non-AF group). Apelin levels were examined from peripheral blood. Results: Apelin was significantly lower in AF group compared to non-AF group (0.694 ± 0.148 vs. 0.975 ± 0.458 ng/ml, p = 0.001) and control group (0.982 ± 0.060 ng/ml, p < 0.001), respectively. Receiver operating characteristic (ROC) analysis of apelin as a predictor of AF scored area under the curve (AUC) of 0.658. Apelin's concentration of 0.969 [ng/ml] had sensitivity = 0.966 and specificity = 0.467. Logistic regression based on manual feature selection showed that only apelin and NT-proBNP were independent predictors of AF. Logistic regression based on selection from bivariate analysis showed that only apelin was an independent predictor of AF. A logistic regression model using repeated stratified K-Fold cross-validation strategy scored an AUC of 0.725 ± 0.131. Conclusions: Our results suggest that apelin might be used to rule out AF in patients with high risk of stroke.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22001569
003      
CZ-PrNML
005      
20220112153639.0
007      
ta
008      
220107s2021 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3389/fcvm.2021.742601 $2 doi
035    __
$a (PubMed)34712712
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Bohm, Allan $u National Institute of Cardiovascular Diseases, Bratislava, Slovakia $u 3rd Department of Internal Medicine, Faculty of Medicine, Comenius University in Bratislava, University Hospital Bratislava, Bratislava, Slovakia $u Premedix Academy, Bratislava, Slovakia
245    10
$a Association Between Apelin and Atrial Fibrillation in Patients With High Risk of Ischemic Stroke / $c A. Bohm, P. Snopek, L. Tothova, B. Bezak, N. Jajcay, M. Vachalcova, T. Uher, M. Kurecko, V. Kissova, K. Danova, P. Olejnik, P. Michalek, T. Hlavata, K. Petrikova, V. Mojto, J. Kyselovic, S. Farsky
520    9_
$a Background: Atrial fibrillation (AF) is associated with high risk of stroke preventable by timely initiation of anticoagulation. Currently available screening tools based on ECG are not optimal due to inconvenience and high costs. Aim of this study was to study the diagnostic value of apelin for AF in patients with high risk of stroke. Methods: We designed a multicenter, matched-cohort study. The population consisted of three study groups: a healthy control group (34 patients) and two matched groups of 60 patients with high risk of stroke (AF and non-AF group). Apelin levels were examined from peripheral blood. Results: Apelin was significantly lower in AF group compared to non-AF group (0.694 ± 0.148 vs. 0.975 ± 0.458 ng/ml, p = 0.001) and control group (0.982 ± 0.060 ng/ml, p < 0.001), respectively. Receiver operating characteristic (ROC) analysis of apelin as a predictor of AF scored area under the curve (AUC) of 0.658. Apelin's concentration of 0.969 [ng/ml] had sensitivity = 0.966 and specificity = 0.467. Logistic regression based on manual feature selection showed that only apelin and NT-proBNP were independent predictors of AF. Logistic regression based on selection from bivariate analysis showed that only apelin was an independent predictor of AF. A logistic regression model using repeated stratified K-Fold cross-validation strategy scored an AUC of 0.725 ± 0.131. Conclusions: Our results suggest that apelin might be used to rule out AF in patients with high risk of stroke.
655    _2
$a časopisecké články $7 D016428
700    1_
$a Snopek, Peter $u Department of Cardiology, Faculty Hospital Nitra, Nitra, Slovakia $u St. Elizabeth University of Health and Social Work in Bratislava, Bratislava, Slovakia
700    1_
$a Tothova, Lubomira $u Institute of Molecular Biomedicine, Faculty of Medicine, Comenius University, Bratislava, Slovakia $u Faculty of Medicine, Comenius University, Bratislava, Slovakia
700    1_
$a Bezak, Branislav $u National Institute of Cardiovascular Diseases, Bratislava, Slovakia $u Faculty of Medicine, Comenius University, Bratislava, Slovakia $u Faculty of Medicine, Slovak Medical University in Bratislava, Bratislava, Slovakia
700    1_
$a Jajcay, Nikola $u Premedix Academy, Bratislava, Slovakia $u Department of Complex Systems, Institute of Computer Science, Czech Academy of Sciences, Prague, Czechia
700    1_
$a Vachalcova, Marianna $u 1st Department of Cardiology, East Slovak Institute of Cardiovascular Diseases, Košice, Slovakia $u Faculty of Medicine, Pavol Jozef Safarik University, Košice, Slovakia
700    1_
$a Uher, Tomas $u Premedix Academy, Bratislava, Slovakia
700    1_
$a Kurecko, Marian $u 1st Department of Cardiology, East Slovak Institute of Cardiovascular Diseases, Košice, Slovakia
700    1_
$a Kissova, Viera $u 1st Department of Internal Medicine, Faculty of Medicine, Comenius University, Bratislava, Slovakia
700    1_
$a Danova, Katarina $u Department of Laboratory Medicine, National Institute of Cardiovascular Diseases, Bratislava, Slovakia
700    1_
$a Olejnik, Peter $u National Institute of Cardiovascular Diseases, Bratislava, Slovakia $u Faculty of Medicine, Comenius University, Bratislava, Slovakia
700    1_
$a Michalek, Peter $u Premedix Academy, Bratislava, Slovakia
700    1_
$a Hlavata, Tereza $u 3rd Department of Internal Medicine, Faculty of Medicine, Comenius University in Bratislava, University Hospital Bratislava, Bratislava, Slovakia $u Faculty of Medicine, Comenius University, Bratislava, Slovakia
700    1_
$a Petrikova, Katarina $u Premedix Academy, Bratislava, Slovakia
700    1_
$a Mojto, Viliam $u 3rd Department of Internal Medicine, Faculty of Medicine, Comenius University in Bratislava, University Hospital Bratislava, Bratislava, Slovakia
700    1_
$a Kyselovic, Jan $u Faculty of Medicine, Comenius University, Bratislava, Slovakia
700    1_
$a Farsky, Stefan $u House of the Heart (Dom Srdca), Slovak League Against Hypertension, Martin, Slovakia
773    0_
$w MED00198704 $t Frontiers in cardiovascular medicine $x 2297-055X $g Roč. 8, č. - (2021), s. 742601
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34712712 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20220107 $b ABA008
991    __
$a 20220112153635 $b ABA008
999    __
$a ind $b bmc $g 1745531 $s 1152716
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 8 $c - $d 742601 $e 20211012 $i 2297-055X $m Frontiers in cardiovascular medicine $n Front Cardiovasc Med $x MED00198704
LZP    __
$a Pubmed-20220107

Najít záznam

Citační ukazatele

Možnosti archivace